Title 21Food and DrugsRelease 119-73

§387v Reporting on tobacco regulation activities

Title 21 › Chapter CHAPTER 9— - FEDERAL FOOD, DRUG, AND COSMETIC ACT › Subchapter SUBCHAPTER IX— - TOBACCO PRODUCTS › § 387v

Last updated Apr 6, 2026|Official source

Summary

The Secretary of Health and Human Services must make and send an annual report for fiscal year 2022 and for every later year when fees are collected under section 387s. The report is due no later than 180 days after the fiscal year ends. It must go to the House Committees on Energy and Commerce and on Appropriations, and to the Senate Committees on Health, Education, Labor, and Pensions and on Appropriations. The report must also be posted on the Food and Drug Administration website. Each report must show key numbers from the previous year. That includes total user fee money collected, how much was spent, and any unused balance carried over. It must say how the Center for Tobacco Products used the money for things like enforcement, public education, scientific work, communications, management, and overhead. The report must list counts of tobacco product applications by product class and by review route under sections 387e, 387j, and 387k and give their status (for example submitted, pending, accepted, refused to file, withdrawn, denied, authorized, given a deficiency or information request, or sent to the Tobacco Products Scientific Advisory Committee). It must list draft and final guidance and rules and whether they met deadlines, public meeting titles and counts, pre-submission meeting requests and waits (including median wait time), number of full-time staff paid from these fees and where they work in FDA, inspections at U.S. and foreign registered establishments, and the total number of enforcement actions (for example warning letters, fines, no-sale orders, seizures, injunctions, and criminal cases). If FDA cannot give exact numbers it may give its best estimates, but it must explain why, give a date it will fix its accounting, and say how it will use lessons from other fee programs to improve accuracy.

Full Legal Text

Title 21, §387v

Food and Drugs — Source: USLM XML via OLRC

(a)For fiscal year 2022 and each subsequent fiscal year for which fees are collected under section 387s of this title, the Secretary of Health and Human Services shall, not later than 180 days after the end of the fiscal year, prepare and submit to the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives, and the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate, an annual report that contains the information required under subsection (b).
(b)Each report submitted under subsection (a) shall contain the following information for the previous fiscal year:
(1)Total annual user fee collections.
(2)Total amount of fees obligated.
(3)The amount of unobligated carryover balance from fees collected.
(4)The amount obligated by the Center for Tobacco Products for each of the following activities:
(A)Compliance and enforcement.
(B)Public education campaigns.
(C)Scientific research and research infrastructure.
(D)Communications.
(E)Leadership, management oversight, and administrative services.
(F)Related overhead activities.
(5)The numbers of applications, categorized by class of tobacco product and review pathway under section 387e, 387j, and 387k of this title, that were—
(A)submitted;
(B)pending;
(C)accepted;
(D)refused to file;
(E)withdrawn;
(F)denied;
(G)authorized for marketing under an order;
(H)issued a deficiency letter or environmental information request letter; or
(I)referred to the Tobacco Products Scientific Advisory Committee.
(6)The number and titles of draft and final guidance documents and proposed and final regulations issued on topics related to the process for the review of tobacco product applications, whether such regulations and guidance documents were issued as required by statute or by other legal or regulatory requirements, and whether the issuance met the deadlines set forth by the applicable statute or other requirements.
(7)The number and titles of public meetings related to the review of tobacco product applications by the Center for Tobacco Products or other offices or centers within the Food and Drug Administration.
(8)The number of pre-submission meetings relating to applications under section 387j of this title, including the number of meeting requests received, the number of meetings held, and the median amount of time between when such meeting requests were made and when the requests were granted or denied.
(9)The number of full-time equivalent employees funded pursuant to fees collected under section 387s of this title, including identification of the centers and offices within the Food and Drug Administration in which such positions are located.
(10)The number of inspections and investigations conducted at domestic and foreign establishments required to register under section 387e of this title.
(11)The total number of compliance and enforcement actions issued or taken with respect to tobacco products, including warning letters, civil money penalties, no-tobacco-sale orders, and other enforcement actions (including seizures, injunctions, and criminal prosecution).
(c)The Secretary of Health and Human Services shall make the reports required under this section available to the public on the website of the Food and Drug Administration.
(d)Reporting under this section shall include best estimates for any reporting category for which the Food and Drug Administration does not have precise calculations. Such best estimates shall be accompanied with an explanatory statement for why the Food and Drug Administration does not have access to, or cannot calculate, the exact figure and a date by which the Food and Drug Administration will update its internal accounting procedures to allow for such reporting. If a category is successfully reported by the Food and Drug Administration with regard to another type of user fee but is provided a best estimate by the Center for Tobacco Products, the explanatory statement shall include information regarding how the Food and Drug Administration will align systems and apply learning across the agency to allow for accurate reporting.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

Codification Section was enacted as part of the Consolidated Appropriations Act, 2022, and not as part of the Federal Food, Drug, and Cosmetic Act which comprises this chapter.

Statutory Notes and Related Subsidiaries

Report on Removal of All Illegal ENDS Products From the Market Pub. L. 119–37, div. B, title VII, § 772(c), Nov. 12, 2025, 139 Stat. 556, provided that: “The Commissioner of Food and Drugs shall submit a semi-annual written report to the Committees on Appropriations of both Houses of Congress on the progress that the Center for Tobacco Products is making in removing all illegal ENDS products from the market: Provided, That the initial report shall be submitted not later than 180 days after the date of enactment of this Act [Nov. 12, 2025].”

Reference

Citations & Metadata

Citation

21 U.S.C. § 387v

Title 21Food and Drugs

Last Updated

Apr 6, 2026

Release point: 119-73